ArticleCancer immunology, immunotherapy : CII2006

Interferon-gamma renders tumors that express low levels of Her-2/neu sensitive to cytotoxic T cells.

Barbara L F Kaplan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.